Series date: 
07/01/2020 - 7:00am CDT to 06/30/2021 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  

Frequency

Semi-Monthly

Series Director

Jacquelyn Powers, MD

Target Audience and Needs

Physicians, fellows, nurse practitioners, nurses, laboratory technicians, allied health professionals, and other healthcare professionals, primarily in the fields of pediatric hematology-oncology, transfusion medicine, and pathology need to be regularly updated on the recent and challenging hematology and coagulation cases, as well as evidence-based approaches for the appropriate identification and management of such patients. The series aims to increase knowledge and skills of the learners in these topic areas in order to enhance the quality of care and improve patient outcomes.

Educational Methods

Educational methods will include lectures, case presentations, and literature review.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Define and describe specific problems in pediatric hematology and coagulation, including transfusion medicine.
  • Determine and interpret available laboratory and radiographic diagnostic tests within the differential diagnosis of pediatric hematologic disorders, including coagulopathies.
  • Utilize clinical findings and laboratory results to diagnose and manage pediatric patients with hematologic disorders and coagulopathies.
  • Identify and differentiate evidence-based therapeutic choices for childhood hematologic disorders and coagulopathies and the complications of their treatment.
Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 
Shelby Lopez
u241005@bcm.edu
832-822-1528
 
Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States
See map: Google Maps

Sessions

Session Date
Juvenile Myelomonocytic Leukemia 07/01/2020 - 8:00am to 9:00am CDT
SARS-COV-2, COVID-19, MISC, PIMS-TS, KD, CAC, and TE 07/08/2020 - 8:00am to 9:00am CDT
Perioperative Transfusions and Venous Thromboembolism 07/22/2020 - 8:00am to 9:00am CDT
Sickle Cell Disease Vaso-occlusive Crisis: Expanding Our Multimodal Armamentarium with Regional Anesthesia 07/29/2020 - 8:00am to 9:00am CDT
Multidisciplinary Case Conference: Bone Marrow Failure 08/12/2020 - 8:00am to 9:00am CDT
New Anticoagulant on the Block: Rivaroxaban Practice Standard 08/19/2020 - 8:00am to 9:00am CDT
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa 08/26/2020 - 8:00am to 9:00am CDT
Social Determinants of Health in Sickle Cell Disease: Best Practices, Ethical Challenges, and System Change 09/02/2020 - 8:00am to 9:00am CDT
Gene Therapy for Ocular Diseases: How Gene Therapy Got to Where We Are Today 09/09/2020 - 8:00am to 9:00am CDT
Advocacy, Health Policy, and Sickle Cell Disease: Historical Perspectives and Current Opportunities 09/16/2020 - 8:00am to 9:00am CDT

Pages